Managing Special Populations Among Patients with Type 2 Diabetes Mellitus.
- Published in:
- Pharmacotherapy, 2011, v. 31, n. 12, p. 65S, doi. 10.1592/phco.31.12.65S
- By:
- Publication type:
- Article
Works matching IS 02770008 AND DT 2011 AND VI 31 AND IP 12
Results: 16
1
2
Intensifying Treatment of Type 2 Diabetes Mellitus: Adding Insulin.
- Published in:
- Pharmacotherapy, 2011, v. 31, n. 12, p. 54S, doi. 10.1592/phco.31.12.54S
- By:
- Publication type:
- Article
3
Beyond Metformin: Initiating Combination Therapy in Patients with Type 2 Diabetes Mellitus.
- Published in:
- Pharmacotherapy, 2011, v. 31, n. 12, p. 44S, doi. 10.1592/phco.31.12.44S
- By:
- Publication type:
- Article
4
Overview of the Guidelines and Evidence for the Pharmacologic Management of Type 2 Diabetes Mellitus.
- Published in:
- Pharmacotherapy, 2011, v. 31, n. 12, p. 37S, doi. 10.1592/phco.31.12.37S
- By:
- Publication type:
- Article
5
Introduction.
- Published in:
- Pharmacotherapy, 2011, v. 31, n. 12, p. 35S, doi. 10.1592/phco.31.12.35S
- By:
- Publication type:
- Article
6
EDITOR'S NOTE.
- Published in:
- Pharmacotherapy, 2011, v. 31, n. 12, p. 35S
- Publication type:
- Article
7
Nephrotoxicity Associated with Intravenous Colistin in Critically Ill Patients.
- Published in:
- Pharmacotherapy, 2011, v. 31, n. 12, p. 1257, doi. 10.1592/phco.31.12.1257
- By:
- Publication type:
- Article
8
Continuous Infusion versus Intermittent Bolus Dosing of Vecuronium in Patients Receiving Therapeutic Hypothermia After Sudden Cardiac Arrest.
- Published in:
- Pharmacotherapy, 2011, v. 31, n. 12, p. 1250, doi. 10.1592/phco.31.12.1250
- By:
- Publication type:
- Article
9
Dabigatran Etexilate in Clinical Practice: Confronting Challenges to Improve Safety and Effectiveness.
- Published in:
- Pharmacotherapy, 2011, v. 31, n. 12, p. 1232, doi. 10.1592/phco.31.12.1232
- By:
- Publication type:
- Article
10
Strategies for Managing Heparin Therapy in Patients with Antiphospholipid Antibody Syndrome.
- Published in:
- Pharmacotherapy, 2011, v. 31, n. 12, p. 1221, doi. 10.1592/phco.31.12.1221
- By:
- Publication type:
- Article
11
Striking a Balance Between the Risks and Benefits of Anticoagulation Bridge Therapy in Patients with Atrial Fibrillation: Clinical Updates and Remaining Controversies.
- Published in:
- Pharmacotherapy, 2011, v. 31, n. 12, p. 1208, doi. 10.1592/phco.31.12.1208
- By:
- Publication type:
- Article
12
Role of Pharmacogenomics in the Management of Traditional and Novel Oral Anticoagulants.
- Published in:
- Pharmacotherapy, 2011, v. 31, n. 12, p. 1192, doi. 10.1592/phco.31.12.1192
- By:
- Publication type:
- Article
13
Novel Oral Anticoagulants and Their Role in Clinical Practice.
- Published in:
- Pharmacotherapy, 2011, v. 31, n. 12, p. 1175, doi. 10.1592/phco.31.12.1175
- By:
- Publication type:
- Article
14
Anticoagulation Patient Self-Monitoring in the United States: Considerations for Clinical Practice Adoption.
- Published in:
- Pharmacotherapy, 2011, v. 31, n. 12, p. 1161, doi. 10.1592/phco.31.12.1161
- By:
- Publication type:
- Article
15
I'm Still Here: Reflections on 39 Years of Clinical Practice in a Community Hospital-Based Anticoagulation Service.
- Published in:
- Pharmacotherapy, 2011, v. 31, n. 12, p. 1156, doi. 10.1592/phco.31.12.1156
- By:
- Publication type:
- Article
16
The Future Landscape of Anticoagulation Management.
- Published in:
- 2011
- By:
- Publication type:
- Editorial